# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-18T00:04:13.798075
**Route:** Direct Google API + PDF
**Tokens:** 20477 in / 2190 out
**Response SHA256:** 6bbc2af318d7c92f

---

This review evaluates the visual exhibits of the paper "Paying More, Getting Less? The Perverse Effects of Medicaid HCBS Reimbursement Rate Increases on Provider Supply" against the standards of top-tier economics journals (AER, QJE, etc.).

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: Pre-ARPA Baseline Period (January 2018–March 2021)"
**Page:** 11
- **Formatting:** Clean, standard LaTeX booktabs style. Appropriate use of horizontal rules.
- **Clarity:** Logical grouping (All/Treated/Never-Treated). Standard deviations are provided.
- **Storytelling:** Essential for establishing baseline comparability. 
- **Labeling:** Good. "Total paid ($)" and "Avg. payment/claim ($)" clearly state units. Notes explain the sample and NPI definition.
- **Recommendation:** **KEEP AS-IS**

### Table 2: "Effect of HCBS Rate Increases on Provider Outcomes"
**Page:** 14
- **Formatting:** Professional. Standard errors in parentheses. Checkmarks for FE are standard.
- **Clarity:** Excellent. Presents the core TWFE results across all outcomes in one place.
- **Storytelling:** The primary "null result" table. Including the "Mean dep. var." at the bottom is helpful for interpreting magnitude.
- **Labeling:** Defines WCB (Wild Cluster Bootstrap) and RI (Randomization Inference) p-values in notes.
- **Recommendation:** **REVISE**
  - **Change:** Decimal-align the coefficients and standard errors to improve vertical scanning. Currently, they are center-aligned, which makes comparing magnitudes slightly harder.

### Table 3: "Callaway-Sant’Anna Staggered DiD Estimates"
**Page:** 15
- **Formatting:** Consistent with Table 2.
- **Clarity:** Side-by-side comparison of ATT vs. TWFE is helpful for the "New DiD" literature requirements.
- **Storytelling:** Addresses the "staggered treatment" bias concern immediately after the main results.
- **Labeling:** Clear. 
- **Recommendation:** **KEEP AS-IS** (Consider merging with Table 2 as Panel B if page count is an issue, but standalone is fine for top journals).

### Figure 1: "Event Study: Provider Participation After Rate Increase"
**Page:** 16
- **Formatting:** Modern, clean "ggplot2" style. Light gridlines are acceptable.
- **Clarity:** Key message (flat pre-trend, null post-trend) is visible in seconds. Pointwise CIs are clear.
- **Storytelling:** Essential for DiD identification.
- **Labeling:** Y-axis clearly labeled. "Quarters Relative to Rate Increase" is the correct unit.
- **Recommendation:** **REVISE**
  - **Change:** Increase the font size of the axis tick labels and the "Source/Notes" text at the bottom. It will be illegible in a printed journal double-column format.

### Figure 2: "Event Study: Beneficiaries Served After Rate Increase"
**Page:** 17
- **Formatting:** Consistent with Figure 1.
- **Clarity:** The green color distinguishes it from the blue provider count figure.
- **Storytelling:** Supporting evidence for the null volume response.
- **Labeling:** "ATT (Log Beneficiaries Served)" is clear.
- **Recommendation:** **MOVE TO APPENDIX**
  - **Reason:** The paper's primary focus is *Provider Supply*. Having two nearly identical event studies in the main text is repetitive. Keep Figure 1 (Providers) in the main text and move Figure 2 (Beneficiaries) to the appendix to tighten the narrative.

### Figure 3: "Personal Care Provider Counts: Treated vs. Never-Treated States"
**Page:** 18
- **Formatting:** Good use of indexing to 100.
- **Clarity:** The "ARPA Enacted" vertical line provides crucial context.
- **Storytelling:** Provides the "raw data" look that reviewers often demand before seeing regression results.
- **Labeling:** Legend is clear.
- **Recommendation:** **KEEP AS-IS**

### Table 4: "Robustness Checks"
**Page:** 19
- **Formatting:** Massive multi-panel table. Efficient use of space.
- **Clarity:** Despite the density, the Panel A–G structure is easy to follow.
- **Storytelling:** This is the "shield" of the paper—it deflects every possible identification critique in one exhibit.
- **Labeling:** Excellent. Defines what changed in each row (e.g., "Excl. WY", "1,000 perms").
- **Recommendation:** **KEEP AS-IS** (Top journals value this comprehensive "Everything Table").

### Figure 4: "Heterogeneous Effects by Provider Type"
**Page:** 20
- **Formatting:** Coefficient plot (forest plot) style.
- **Clarity:** Shows the "suggestive decline" in individuals vs. others very effectively.
- **Storytelling:** Visualizes Table 4 Panel C.
- **Labeling:** Clear category names.
- **Recommendation:** **KEEP AS-IS**

### Figure 5: "Randomization Inference: Provider Count Effect"
**Page:** 22
- **Formatting:** Standard RI histogram.
- **Clarity:** Shows the observed beta relative to the null distribution clearly.
- **Storytelling:** Adds robustness to the p-values.
- **Labeling:** Legend identifies the observed beta and p-value.
- **Recommendation:** **MOVE TO APPENDIX**
  - **Reason:** While rigorous, this is a "methodological" check. The result is already summarized in Table 2 and Table 4. It takes up a full page but doesn't change the supply-side story.

### Figure 6: "Dose-Response: Rate Increase Size and Provider Supply"
**Page:** 23
- **Formatting:** Scatter with OLS fit. 
- **Clarity:** Clear labeling of the outlier (Wyoming) being excluded.
- **Storytelling:** Important for showing that even *huge* raises didn't move the needle.
- **Labeling:** "Rate Increase Magnitude (%)" on x-axis is intuitive.
- **Recommendation:** **KEEP AS-IS**

### Figure 7: "Organizational Billing Share: Treated vs. Never-Treated States"
**Page:** 25
- **Formatting:** Time-series plot.
- **Clarity:** The y-axis (94%-98%) is very zoomed in, which might exaggerate small noise.
- **Storytelling:** Directly addresses the "Consolidation" mechanism.
- **Labeling:** "Vertical line marks ARPA enactment" is helpful.
- **Recommendation:** **REVISE**
  - **Change:** Add a note or a secondary axis to show the total number of NPIs. Also, consider if a regression-based event study of "Org Share" (Table 4, Panel G) is more convincing than this raw plot, which shows significant volatility for the "Treated" group in 2024.

---

## Appendix Exhibits

### Table 5: "Treatment Validation: Detected vs. Documented Rate Increases"
**Page:** 34
- **Formatting:** List format.
- **Clarity:** Crucial for "grounding" the data-driven algorithm in reality.
- **Storytelling:** High-value for the appendix; builds trust in the identification.
- **Recommendation:** **KEEP AS-IS**

### Table 6: "Detected HCBS Rate Increases by State"
**Page:** 34
- **Formatting:** Large table, legible.
- **Clarity:** Shows the wide variation in "Rate Before" (from $0.92 to $1458). 
- **Storytelling:** Explains why "log" transformations and "outlier" checks (Wyoming) are necessary.
- **Recommendation:** **KEEP AS-IS**

### Table 7: "Sun-Abraham Interaction-Weighted Estimates: Log Providers"
**Page:** 35
- **Formatting:** Tabular coefficients.
- **Clarity:** Logical but less visual than the event study.
- **Storytelling:** Technical robustness for the CS-DiD results.
- **Recommendation:** **KEEP AS-IS**

---

## Overall Assessment

- **Exhibit count:** 4 Tables (Main), 6 Figures (Main), 3 Tables (Appendix), 0 Figures (Appendix).
- **General quality:** Extremely high. The paper follows modern "New DiD" transparency standards. The use of both TWFE and CS-DiD, supplemented by RI and Wild Cluster Bootstrap, is "Econometrica-ready."
- **Strongest exhibits:** Table 4 (Robustness) and Figure 1 (Event Study).
- **Weakest exhibits:** Figure 5 (RI) and Figure 7 (Org Share).
- **Missing exhibits:** 
    1. **A Map:** A choropleth map of the US showing "Treated" vs. "Control" states and the timing/magnitude of increases would be a standard "Figure 1" for this type of paper.
    2. **Balance Plot:** A visual representation of pre-treatment balance on covariates (if any are used, though this paper relies on FE).
- **Top 3 improvements:**
  1. **Consolidate/Prune Main Text Figures:** Move Figure 2 (Beneficiaries) and Figure 5 (RI) to the Appendix to keep the main text focused on the core Provider Supply result.
  2. **Add a Treatment Map:** Create a geographic visualization of the 20 treated jurisdictions to help readers understand the spatial distribution of the policy shocks.
  3. **Standardize Font Sizes:** Ensure all figure axis labels and source notes are at least 8-9pt font when scaled to a journal page; currently, some figure text is too small.